LHP brings together the multidisciplinary wealth of expertise in anti-infective research and is well-positioned to adopt a one health approach for the region.


  • Infection can affect any area of the body from the lungs (pneumonia) to the brain, nervous system (meningitis or encephalitis), bones (osteomyelitis) and bladder, urethra or kidneys (urinary tract infection or UTI).
  • If the immune system is weak or an infection is particularly severe, it can spread through the blood to other parts of the body, causing inflammation and have damaging consequences.
  • We estimate that in Liverpool, there have been just over 85,000 admissions to our hospitals as a result of serious infection since 2013.
  • Infection prevention and control (IPC) is a practical evidence-based approach to prevent harm to patients and health care workers, which includes practising hand hygiene, maintaining a clean environment, monitoring infection and taking action to reduce its frequency, in addition to using antibiotics only when they are truly needed, to reduce the risk of resistance.
  • Antimicrobials are fundamental components of our health system and antimicrobial resistance (AMR) strikes the poor hardest.
  • The burden of AMR is wider than the health of the individual, their family and the wellbeing of their local community: treatment of resistant infections is expensive. The cost of AMR is predicted to be £78.7 trillion globally by 2050, driving an additional 28 million people into poverty.


  • The scale of the problem, which is recognised by the UK Government in its plans to address AMR and the NHS Long Term Plan, combined with our academic strength in Liverpool, makes infection a priority for Liverpool Health Partners.
  • Prevention, detection and appropriate treatment of infection can help patients lead healthier lives for longer.
  • The potential benefits to society of discoveries and advancement in anti-infective research is huge in terms of health and wealth.

One of our key objectives under this theme is to support a successful NIHR Biomedical Research Centre (BRC) application in 2021. Liverpool’s 2021 submission will reflect the universal, multidisciplinary perspective of the Universities and NHS in Liverpool, focussing on its academic strength and demonstrated track record of excellence and achievement, to address the health of the local, regional and national populations, using team-based problem solving.

For more information about this research programme, please contact Elizabeth Collins by email at

Sign up for our newsletter

If you would like to receive quarterly newsletters from Liverpool Health Partners please sign up here. We won’t use your details for any other purpose, and we won’t pass them on to any other organisation.